Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 44.21%. However, over the last six months, the performance has been stronger by -19.18%. The price of NNVC increased 9.77% over the last 30 days. And in the last five days, it has fallen by -1.28%.
NanoViricides Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $3.59 on 06/10/24, while the lowest price for the same period was registered at $1.00 on 12/29/23.
52-week price history of NNVC Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. NanoViricides Inc’s current trading price is -57.94% away from its 52-week high, while its distance from the 52-week low is 50.98%. The stock’s price range during this period has varied between$1.00 and $3.59. The NanoViricides Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.28 million for the day, a figure considerably higher than their average daily volume of 0.2 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
NanoViricides Inc (NNVC) has experienced a quarterly rise of 8.96% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 21.10M and boasts a workforce of 7 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.5641, with a change in price of -0.5900. Similarly, NanoViricides Inc recorded 207,611 in trading volume during the last 100 days, posting a change of -28.10%.
NNVC’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NNVC stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
NNVC Stock Stochastic Average
As of today, NanoViricides Inc’s raw stochastic average for the last 50 days stands at 81.58%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 75.00%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 77.78% and 74.42%, respectively.
